var text = [{"boxId":"1","infoText":"Percutaneous Coronary Intervention","boxType":BoxTypes.ACTIVITY_STARTING_POINT,"nextBox":"2"},{"boxId":"2","infoText":"Treatment indication","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"Stable Coronary Artery Disease","eventAction":"3"},{"text":"Acute Coronary Syndrome","eventAction":"8"}]},{"boxId":"3","infoText":"Device used","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"DES\/BMS or DCB","eventAction":"4"},{"text":"BRS","eventAction":"7"}]},{"boxId":"4","infoText":"High Bleeding Risk","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"5"},{"text":"Yes","eventAction":"6"}]},{"boxId":"5","infoText":"<ul>\n<li>DAPT for upto 6 months (A, C) (<em>Class I A<sup>1<\/sup></em>)<\/li>\n<li>Continue DAPT &gt;6 months (A, C) (<em>Class IIb A</em>)<\/li>\n<\/ul>","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"6","infoText":"<ul>\n<li>DAPT for upto 1 month (A, C) <em>(Class IIb C)</em>\n<\/li>\n<li>DAPT for upto 3 months (A, C) <em>(Class IIa B)</em>\n<\/li>\n<\/ul>","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"7","infoText":"Dapt for ≥12 months (A, P OR A, T OR, A, C<sup>2<\/sup>) (<em>Class IIa C</em>)","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"8","infoText":"Device used","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"DES\/BMS or DCB","eventAction":"9"},{"text":"BRS","eventAction":"7"}]},{"boxId":"9","infoText":"High Bleeding Risk","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"10"},{"text":"Yes","eventAction":"11"}]},{"boxId":"10","infoText":"<ul>\n<li>DAPT for upto 12 months (A, P OR A, T OR A, C<sup>3<\/sup>) (<em>Class I A</em>)<\/li>\n<li>Continue DAPT for &gt;12 months in pts with prior MI (A, T OR A, P<sup>4<\/sup> OR A, C<sup>4<\/sup>) (<em>Class IIb B</em>)<\/li>\n<\/ul>","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"11","infoText":"DAPT for upto 6 months (A, C OR A, T) (<em>Class IIa B</em>)","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"998","boxType":BoxTypes.FOOTER,"hasFootnote":true,"referenceText":"High bleeding risk is considered as an increased risk of spontaneous bleeding during DAPT (e.g. PRECISE-DAPT score ≥25).<br>Colour-coding refers to the ESC Classes of Recommendations (green = Class I; yellow = Class IIa; orange = Class IIb).<br>Treatments presented within the same line are sorted in alphabetic order, no preferential recommendation unless clearly stated otherwise.<br><sup>1<\/sup>After PCI with DCB 6 mo. DAPT should be considered (Class IIa B).<br><sup>2<\/sup>if patient presents with SCAD or, in case of ACS, is not eligible for a treatment with prasugrel or ticagrelor.<br><sup>3<\/sup>if patient is not eligible for a treatment with prasugrel or ticagrelor.<br><sup>4<\/sup>if patient is not eligible for a treatment with ticagrelor.","hasAbbreviation":true,"abbreviationText":"A = Aspirin; C = Clopidogrel; P = Prasugrel; T = Ticagrelor; ACS = acute coronary syndrome; BMS = bare-metal stent; BRS = bioresorbable vascular scaffold; CABG = coronary artery bypass graft; DCB = drug-coated balloon; DES: drug-eluting stent; Stable CAD = stable coronary artery disease.","staticImageName":"interactive_0001452","extraButtons":[{"buttonRow":[{"text":"Abbreviation(s) and Footnote(s)","buttonId":FooterButtons.REF_BUTTON},{"image":"Flip PDF","buttonId":FooterButtons.PDF_BUTTON}]},{"buttonRow":[{"text":"Reset","buttonId":FooterButtons.RESET_BUTTON},{"text":"<a class='more-info-link' href='ref_ENAS5326_5.4.0.0.html'>More information</a>","buttonId":FooterButtons.MORE_INFO_BUTTON}]}]}];